Hematoloxía

2024

1. A multicentre ambispective observational study into the incidence and clinical management of aplastic anaemia in Spain (IMAS study)

   Annals of Hematology, Vol. 103, Núm. 3, pp. 705-713

2. ADAMTS13 recovery in acute thrombotic thrombocytopenic purpura after caplacizumab therapy

   Blood, Vol. 143, Núm. 18, pp. 1807-1815

3. Activity and safety of eltrombopag in combination with cyclosporin A as first‑line treatment of adults with severe aplastic anaemia (SOAR): a phase 2, single-arm study

   The Lancet Haematology, Vol. 11, Núm. 3, pp. e206-e215

4. Avatrombopag in immune thrombocytopenia: A real-world study of the Spanish ITP Group (GEPTI)

   American Journal of Hematology

5. Bloqueo de las ramas cutáneas anteriores de los nervios intercostales para el control del dolor crónico por infiltración tumoral de carcinoma de mama metastásico

   MPJ Multidisciplinary Pain Journal, Núm. 1

6. Cardiac events occurring after allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide. Study conducted on behalf of the GETH-TC

   Bone Marrow Transplantation

7. Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022

   eClinicalMedicine, Vol. 71

8. Do NPM1 and FLT3-ITD mutations modify prognosis in patients treated with non-intensive regimens?

   Annals of Hematology, Vol. 103, Núm. 8, pp. 2845-2851

9. Evolving patterns and clinical outcome of genetic studies performed at diagnosis in acute myeloid leukemia patients: Real life data from the PETHEMA Registry

   Cancer, Vol. 130, Núm. 20, pp. 3436-3451

10. Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice

    Blood, Vol. 144, Núm. 6, pp. 646-656

11. Incidence, risk factors, and outcomes of second neoplasms in patients with acute promyelocytic leukemia: the PETHEMA-PALG experience

    Annals of Hematology, Vol. 103, Núm. 2, pp. 451-461

12. Outcomes after intensive chemotherapy for secondary and myeloid-related changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry

    Haematologica, Vol. 109, Núm. 1, pp. 115-128

13. Predictors of unsustained measurable residual disease negativity in transplant-eligible patients with multiple myeloma

    Blood, Vol. 143, Núm. 7, pp. 597-603

14. Prognostic and survival factors in head and neck extra-nodal non-Hodgkin's lymphoma

    Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

15. Prognostic value of response to first-line hydroxyurea according to IPSET stratification in essential thrombocythemia

    Leukemia

16. Transfusion medicine in our environment: Opportunities and threats

    Vox Sanguinis, Vol. 119, Núm. S1, pp. LD02-L01

17. Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification

    British Journal of Haematology, Vol. 204, Núm. 4, pp. 1529-1535